MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it, along with several other opponents, successfully opposed Edwards Lifesciences Corporation’s European patent EP 2,399,550 (‘550) in the European Patent Office (EPO), resulting in a revocation of […]
Tag: TAVI
Global Transcatheter Aortic Valve Implantation (TAVI) Market Analysis & Outlook 2018-2022 with Profiles of Abbott Laboratories, Boston Scientific, Edwards Lifesciences & Medtronic – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering. “Global TAVI Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market, with focus on the U.S and European markets. The […]
Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing
DUBLIN – July 31, 2017 – Medtronic plc (NYSE:MDT) today announced CE (Conformité Européenne) mark and European launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at intermediate, high or extreme risk for […]
Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation
MUNICH, April 27, 2017 /PRNewswire/ — ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation Study adds to the growing […]
Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of EMBLOK Embolic Protection System
NEWS PROVIDED BY Innovative Cardiovascular Solutions 15 Mar, 2017, 15:09 ET SHARE THIS ARTICLE MILAN, March 15, 2017 /PRNewswire/ — Innovative Cardiovascular Solutions (ICS), a privately held medical device company pioneering novel solutions for embolic protection during transcatheter aortic valve replacement […]